Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pirtobrutinib is an inhibitor of Bruton’s tyrosine kinase (BTK).1 It inhibits wild-type and mutant BTK (IC50s = 10-100 and <10 nM for wild-type BTK and BTKC481S, respectively). It is selective for BTK over EGFR (IC50 = 1-10 µM). Pirtobrutinib decreases the number of Ki67-positive cells, a marker of cell proliferation, in MEC-1 chronic lymphocytic leukemia (CLL) mouse xenograft models using MEC-1 cells that express either wild-type BTK or BTKC481S.2
WARNING This product is not for human or veterinary use.
1. Compounds useful as kinase inhibitors. (2017).
2. Pirtobrutinib inhibits wild-